≪英文≫

Age-stratified outcomes of radical cystectomy for muscle-invasive bladder cancer: a nationwide multicenter study of 1867 patients in Japan.

Kawai T, Miki J, Taoka R, Saito R, Fukuokaya W, Matsui Y, Fujii Y, Hatakeyama S, Kawahara T, Matsuda A, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Nakayama M, Matsumoto T, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Kobayashi K, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Kume H; Japan Urological Oncology Group.

Jpn J Clin Oncol. 2026 Jan 16. doi: 10.1093/jjco/hyaf218. Online ahead of print. PMID: 41543041

 

Longitudinal Impact of Urinary Diversion on Health-Related Quality of Life After Radical Cystectomy: A Multicenter Study in Japan.

Yamada S, Sato M, Osawa T, Harabayashi T, Miki J, Kobayashi T, Hashine K, Kawashima A, Matsumoto T, Mochizuki T, Taoka R, Urabe F, Tatarano S, Sawada A, Kojima T, Takahashi A, Yokomizo A, Suekane S, Hashimoto K, Hashimoto Y, Yatsuda J, Morita K, Kobayashi K, Satake Y, Sazawa A, Matsui Y, Ito YM, Shimizu S, Fukuhara S, Nishiyama H, Kitamura H, Shinohara N; Japanese Urological Oncology Group.

Cancer Sci. 2026 Jan 4. doi: 10.1111/cas.70289. Online ahead of print. PMID: 41486068

 

Genetically engineered human iPS cell-derived kidney organoid recapitulates an early stage of ALK fusion gene-associated renal tumorigenesis.

Noguchi G, Baba M, Ohtake S, Jikuya R, Mitome T, Kawamura S, Aomori K, Iribe Y, Nagasaka H, Wilan K, Funasaki S, Muraoka E, Fujii S, Tsuzuki T, Kato I, Furuya M, Nagashima Y, Nishizawa H, Kamba T, Kuraoka S, Kawagoe T, Mizuki N, Tatenuma T, Ueno D, Kawahara T, Ito H, Komeya M, Ito Y, Muraoka K, Uemura H, Tamura T, Ogawa T, Suda T, Yao M, Makiyama K, Nakagawa H, Shuch BM, Ricketts CJ, Schmidt LS, Linehan WM, Nishinakamura R, Hasumi H.

Mol Cancer Res. 2025 Dec 22. doi: 10.1158/1541-7786.MCR-25-0043. Online ahead of print. PMID: 41427836

 

Effectiveness and Safety of Radium-223 for Bone-Metastatic Castration-Resistant Prostate Cancer: The KYUCOG-1901 Study.

Shiota M, Tatarano S, Kamba T, Kamaoto T, Igawa T, Masumori N, Uemura H, Mitsunari K, Sumiyoshi T, Uemura H, Higashijima K, Tokunaga S, Eto M.

Cancer Sci. 2026;117(2):501-510.

Comparison of first-line immuno-oncology combinations with molecular targeted therapy in patients with advanced renal cell carcinoma undergoing hemodialysis: a real-world multicenter retrospective study.

Ueda K, Kurata H, Murakami Y, Minato A, Shiota M, Nakanishi S, Kiyoshima K, Inoue T, Kumagae H, Irie S, Noguchi M, Tatarano S, Matsuzaki H, Tokuda Y, Sawada A, Abe T, Oshiro Y, Harada S, Igawa T.

Int J Clin Oncol. 2026;31(1):160-171.

 

Comprehensive Histopathological and Biochemical Analyzes of Prostatic Amyloid Bodies (Corpora Amylacea) From Autopsy Samples From Japanese Patients.

Yatsuda J, Kanenawa K, Nomura T, Okada M, Masuda T, Misumi Y, Tasaki M, Ueda M, Ando Y, Kamba T.

Prostate. 2026;86(1):116-123.

 

≪和文≫